P53 is unstable during metastatic development of the human breast cancer: A comparison between the primary tumor and lymph node metastasis
Objective. The aim of this study was to highlight p53 expression during metastatic progression of invasive breast carcinoma of no special type (NST) and to evaluate its role in stratifying patients based on molecular classification. Material and Methods. The specimens, primary tumors and correspon...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Victor Babes University of Medicine and Pharmacy Timisoara
2017-06-01
|
| Series: | Research and Clinical Medicine |
| Subjects: | |
| Online Access: | http://www.resclinmed.eu/public/data_files/articles/18/article_18.pdf |
| _version_ | 1818753612030935040 |
|---|---|
| author | Veaceslav Fulga |
| author_facet | Veaceslav Fulga |
| author_sort | Veaceslav Fulga |
| collection | DOAJ |
| description | Objective. The aim of this study was to highlight p53 expression during metastatic progression of invasive breast carcinoma of no special
type (NST) and to evaluate its role in stratifying patients based on molecular classification. Material and Methods. The specimens, primary
tumors and corresponding lymph node metastases (LNM) from 84 patients were immunohistochemically stained for estrogen receptor (ER),
progesterone receptor (PR), human epidermal growth factor receptor (HER)-2, basal cytokeratin CK5 and nuclear proteins Ki67, p53. Results.
No statistical significant differences of p53 expression were found between the two compared sites, but the p53 instability was found in 11 cases
(13.2%). Switch of molecular subtype was noticed in 22.62% of cases. Only 5 cases of p53 transitions, from positive to negative status, were
involved in molecular subtypes switch, from Luminal B to Luminal A. Conclusions. The p53 marker and molecular subtypes are not stable
during tumor progression. Breast cancer during its metastatic development can gain or lose the p53 expression and cases developed with p53
vanishing in metastasis prevailed. A link between p53 instability and molecular subtypes switch was found only between p53 loss and Luminal
B to Luminal A transition. |
| first_indexed | 2024-12-18T05:10:07Z |
| format | Article |
| id | doaj.art-476a55060eea41c4b07fb90dfbd7a747 |
| institution | Directory Open Access Journal |
| issn | 2360-1124 2537-5393 |
| language | English |
| last_indexed | 2024-12-18T05:10:07Z |
| publishDate | 2017-06-01 |
| publisher | Victor Babes University of Medicine and Pharmacy Timisoara |
| record_format | Article |
| series | Research and Clinical Medicine |
| spelling | doaj.art-476a55060eea41c4b07fb90dfbd7a7472022-12-21T21:19:54ZengVictor Babes University of Medicine and Pharmacy TimisoaraResearch and Clinical Medicine2360-11242537-53932017-06-01I2610P53 is unstable during metastatic development of the human breast cancer: A comparison between the primary tumor and lymph node metastasisVeaceslav Fulga0 Department of Histology, Cytology and Embryology, Nicolae Testemitanu State University of Medicine and Pharmacy, Chisinau, Republic of MoldovaObjective. The aim of this study was to highlight p53 expression during metastatic progression of invasive breast carcinoma of no special type (NST) and to evaluate its role in stratifying patients based on molecular classification. Material and Methods. The specimens, primary tumors and corresponding lymph node metastases (LNM) from 84 patients were immunohistochemically stained for estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor (HER)-2, basal cytokeratin CK5 and nuclear proteins Ki67, p53. Results. No statistical significant differences of p53 expression were found between the two compared sites, but the p53 instability was found in 11 cases (13.2%). Switch of molecular subtype was noticed in 22.62% of cases. Only 5 cases of p53 transitions, from positive to negative status, were involved in molecular subtypes switch, from Luminal B to Luminal A. Conclusions. The p53 marker and molecular subtypes are not stable during tumor progression. Breast cancer during its metastatic development can gain or lose the p53 expression and cases developed with p53 vanishing in metastasis prevailed. A link between p53 instability and molecular subtypes switch was found only between p53 loss and Luminal B to Luminal A transition.http://www.resclinmed.eu/public/data_files/articles/18/article_18.pdfp53molecular subtypesbreast cancermetastases. |
| spellingShingle | Veaceslav Fulga P53 is unstable during metastatic development of the human breast cancer: A comparison between the primary tumor and lymph node metastasis Research and Clinical Medicine p53 molecular subtypes breast cancer metastases. |
| title | P53 is unstable during metastatic development of the human breast cancer: A comparison between the primary tumor and lymph node metastasis |
| title_full | P53 is unstable during metastatic development of the human breast cancer: A comparison between the primary tumor and lymph node metastasis |
| title_fullStr | P53 is unstable during metastatic development of the human breast cancer: A comparison between the primary tumor and lymph node metastasis |
| title_full_unstemmed | P53 is unstable during metastatic development of the human breast cancer: A comparison between the primary tumor and lymph node metastasis |
| title_short | P53 is unstable during metastatic development of the human breast cancer: A comparison between the primary tumor and lymph node metastasis |
| title_sort | p53 is unstable during metastatic development of the human breast cancer a comparison between the primary tumor and lymph node metastasis |
| topic | p53 molecular subtypes breast cancer metastases. |
| url | http://www.resclinmed.eu/public/data_files/articles/18/article_18.pdf |
| work_keys_str_mv | AT veaceslavfulga p53isunstableduringmetastaticdevelopmentofthehumanbreastcanceracomparisonbetweentheprimarytumorandlymphnodemetastasis |